Refine by
Medical Diagnostic Articles & Analysis: Older
166 news found
In vitro diagnostics (IVD) are tests done on samples such as blood or tissue for the purpose of detecting diseases or other conditions. ...
Today, DNAnexus has more than 12,000 users across 48 countries and works with the largest and most innovative pharmaceutical companies, diagnostic laboratories, and academic medical centers around the world, along with the UK Biobank and the FDA. ...
Quantum points have revealed great potential in analytical applications, but their emission wavelengths in the visible region limit their application, especially in fluorescence imaging for medical diagnostics. Given this, researchers often systematically tune quantum dots to emit different wavelengths, from the visible to the near-infrared region, by adjusting ...
Anavasi Diagnostics ('Anavasi'), a medical technology company focused on the development of novel molecular diagnostic testing, recently announced the addition of a Chief Financial Officer, Chief Operating Officer and Chief Commercial Officer to its management roster. ...
(NASDAQ:BTCY) (“Biotricity” or the “Company”), a medical diagnostic and consumer healthcare technology company, today announced that Waqaas Al-Siddiq, Founder and CEO, is scheduled to participate in a panel discussion at the American Medical Device Summit on October 19, 2022 in Chicago, Illinois. American ...
Among the four initial A.C.T.S. awardees are two companies: Framingham-based Kephera Diagnostics and Wellesley-based Virex Health; and two research hospitals: Beth Israel Deaconess Medical Center and Brigham and Women’s Hospital. ...
(NASDAQ:BTCY) (“Biotricity” or the “Company”), a medical diagnostic and consumer healthcare technology company, today announced a significant milestone of recording and analyzing over 2 billion heartbeats for Atrial Fibrillation (AFib), the most common type of cardiac arrhythmia and a leading cause of stroke. ...
Recent advances in the architecture and scale of AI are leading us from the era of narrowly focused AI (e.g. text auto-complete, immune epitope prediction in a protein sequence, antibody domain detection) to broader models with applications across domains from sales and marketing to medical diagnostics. In protein biochemistry these are the “AIFold” ...
He has an extensive background in manufacturing operations management in the medical industry, including diagnostics, surgical tools, and point-of-care equipment. ...
Founded in 2020 in response to the COVID-19 pandemic, Virusight, which is an AI software company, was created to develop an accurate, real-time virus diagnosis solution. The company uses unique spectral acquisition and analysis technology, for pathogenic diagnosis. The company is currently in the midst of developing and testing revolutionary COVID-19 rapid tests, based on Newsight ...
Proprio’s vice president of product management and marketing, Tommy Carls, has been featured in Medical Device and Diagnostic Industry (“MD&DI”). Carls’ thought leadership piece, “Bringing Intentionality & Defined Purpose to the Road to Data Intelligence” highlights the undervalued influence of healthcare data, and the ...
INOVIQ (ASX:IIQ) is developing and commercialising next-generation exosome capture tools and precision diagnostics in what CEO Dr Leearne Hinch says is a $15bn medical diagnostics market opportunity for some of the most common – and deadly - cancers. “There’s a clear unmet need for earlier and more accurate cancer ...
(NASDAQ:BTCY) (“Biotricity” or the “Company”), a medical diagnostic and consumer healthcare technology company, today announced that it will be carrying out an NIH-sponsored Phase I study of Bioflux-AI, Biotricity’s innovative artificial intelligence-driven (‘AI’) system of real-time monitoring and prediction technology, ...
A major study published in leading cancer journal, The Lancet Oncology1 have ground-breaking findings on Michelson Diagnostics, the UK based medical device company that use multi-beam Optical Coherence Tomography (‘OCT’) technology, which can transform patient’s treatment and care of basal cell carcinomas (BCC). ...
Demonstrated 98% NPV1 to Identify COVID-19 Patients at Risk for Severe Illness Study Data Indicate Symphony IL-6 Test Could be a Rapid and Precise Diagnostic Platform for Near-Patient Management of Critical Care Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical ...
Buechel, currently the Chief Operating Officer of Delfi Diagnostics, brings decades of life science experience developing and commercializing novel healthcare technologies from concept to market. ...
I am very impressed with the commitment of the Cathbot team and the medical staff. They worked very hard to make it happen on time and to maintain our strategic plans despite the lockdowns. ...
ByRobocath
Dear business partners, We would like to thank you for your trust and the good cooperation and look forward to developing and producing many more innovative products for the medical, laboratory and diagnostics field together with you. Paul W. ...
Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay”, “the Company”), a medical diagnostics company focused on developing cost-effective, rapid, near-patient products for triage and monitoring of disease progression, today announced completion of its previously planned clinical studies for the Symphony IL-6 Test (the ...
STEMart, a provider of CRO services dedicated to integrated medical device and diagnostic clinical development, introduced new Antibiotic Potency Tests to assess the bioactivity or potency of various antibiotics for medical devices. ...
BySTEMart